|Min SIP Amount||Not Supported|
|NAV||₹6.14 (15 Jul 2020)|
|Fund Started||21 Dec 2017|
|Fund Size||₹114 Cr|
|Bayer CropScience Ltd.||Healthcare||Equity||8.0%|
|Deepak Nitrite Ltd.||Chemicals||Equity||4.8%|
|Orient Electric Ltd.||Engineering||Equity||4.5%|
|CreditAccess Grameen Ltd.||Financial||Equity||4.4%|
|Indian Energy Exchange Ltd.||Financial||Equity||4.4%|
|Chennai Petroleum Corpn. Ltd.||Energy||Equity||4.2%|
|Bajaj Consumer Care Ltd.||FMCG||Equity||4.2%|
|Valiant organics Ltd||Healthcare||Equity||3.6%|
|Birla Corporation Ltd.||Construction||Equity||3.1%|
Nippon India Capital Builder Fund IV Series C Direct Growth is a Equity Mutual Fund Scheme launched by Nippon India Mutual Fund. This scheme was made available to investors on 21 Dec 2017. Samir Rachh, Jahnvee Shah, Meenakshi Dawar, Dhrumil Shah is the Current Fund Manager of Nippon India Capital Builder Fund IV Series C Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹114 Cr and the Latest NAV as of 15 Jul 2020 is ₹6.14.
The Nippon India Capital Builder Fund IV Series C Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 500.
The investment objective of the scheme is to provide capital appreciation to the investors, which will be in line with their long term savings goal, by investing in a diversified portfolio of equity & equity related instruments with small exposure to fixed income securities. Although, the objective of the Fund is to generate optimal returns, the objective may or may not be achieved.